Tedizolid Phosphate for the Management of Acute Bacterial Skin and Skin Structure Infections: Efficacy Summary
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tedizolid Phosphate for the Management of Acute Bacterial Skin and Skin Structure Infections: Efficacy Summary
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 58, Issue suppl 1, Pages S43-S50
Publisher
Oxford University Press (OUP)
Online
2013-12-17
DOI
10.1093/cid/cit617
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vitro,In Vivo, and Clinical Studies of Tedizolid To Assess the Potential for Peripheral or Central Monoamine Oxidase Interactions
- (2013) S. Flanagan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tedizolid Phosphate for the Management of Acute Bacterial Skin and Skin Structure Infections: Safety Summary
- (2013) D. Das et al. CLINICAL INFECTIOUS DISEASES
- Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections
- (2013) Philippe Prokocimer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010
- (2012) William R. Jarvis et al. AMERICAN JOURNAL OF INFECTION CONTROL
- In VitroActivity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections
- (2012) Philippe Prokocimer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes
- (2012) Benjamin A Lipsky et al. BMC INFECTIOUS DISEASES
- Emergency Department Visit Rates for Abscess Versus Other Skin Infections During the Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus, 1997–2007
- (2012) Munirih L. Qualls et al. CLINICAL INFECTIOUS DISEASES
- Progress on Developing Endpoints for Registrational Clinical Trials of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections: Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health
- (2012) George H. Talbot et al. CLINICAL INFECTIOUS DISEASES
- Overcoming the challenges to developing new antibiotics
- (2012) David M Shlaes et al. CURRENT OPINION IN PHARMACOLOGY
- Improving known classes of antibiotics: an optimistic approach for the future
- (2012) Karen Bush CURRENT OPINION IN PHARMACOLOGY
- Tedizolid (TR-701): a new oxazolidinone with enhanced potency
- (2012) Zeina A. Kanafani et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers
- (2012) Martina Sahre et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods
- (2012) Stefania Stefani et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The emerging problem of linezolid-resistant Staphylococcus
- (2012) B. Gu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In VivoPharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Strains in a Mouse Thigh Infection Model
- (2011) Arnold Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Granulocytes on the Antimicrobial Effect of Tedizolid in a Mouse Thigh Infection Model
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Impact of Antimicrobial Resistance in European Hospitals: Excess Mortality and Length of Hospital Stay Related to Methicillin-ResistantStaphylococcus aureusBloodstream Infections
- (2011) Marlieke E. A. de Kraker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of Staphylococcus aureus From Skin and Soft-Tissue Infections in US Emergency Department Patients, 2004 and 2008
- (2011) D. A. Talan et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach
- (2011) Adrien Fischer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus
- (2010) Kamal M.F. Itani et al. AMERICAN JOURNAL OF SURGERY
- Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections
- (2010) P. Prokocimer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection
- (2010) G. Ralph Corey et al. CLINICAL INFECTIOUS DISEASES
- Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)
- (2009) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin
- (2009) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: A retrospective cohort study utilizing the Cubicin® Outcomes Registry and Experience
- (2009) George Sakoulas et al. CLINICAL THERAPEUTICS
- Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci
- (2009) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Waves of resistance: Staphylococcus aureus in the antibiotic era
- (2009) Henry F. Chambers et al. NATURE REVIEWS MICROBIOLOGY
- Treatment of Complicated Skin and Soft Tissue Infections
- (2009) Addison K. May et al. Surgical Infections
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
- (2008) M. Rybak et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Increased US Emergency Department Visits for Skin and Soft Tissue Infections, and Changes in Antibiotic Choices, During the Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus
- (2008) Daniel J. Pallin et al. ANNALS OF EMERGENCY MEDICINE
- What Is Community‐Associated Methicillin‐ResistantStaphylococcus aureus?
- (2008) Michael Z. David et al. JOURNAL OF INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started